Ledger.Open graph →

SEC Form D · filed November 30, 2017

Codiak BioSciences, Inc

Offering

$76.5M

Sold

—

Exemption

Rule 506(b)

Industry

Biotechnology

Location

Cambridge, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Charles L. Cooney · Cambridge, MADirector Noubar Afeyan · Cambridge, MADirector Steven Gillis · Ann Arbor, MIDirector Eric Lander · Seattle, WADirector Raghu Kalluri · Cambridge, MADirector Doug Williams · Seattle, WAExec · Director Charles L. Cooney · Cambridge, MADirector Eric Lander · Seattle, WADirector Raghu Kalluri · Cambridge, MADirector Noubar Afeyan · Cambridge, MADirector Doug Williams · Seattle, WAExec · Director Steven Gillis · Chicago, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗